Improved botulinum toxin compositions

Details for Australian Patent Application No. 2006275999 (hide)

Owner Allergan, Inc.

Inventors Hunt, Terrence J.

Agent Davies Collison Cave

Pub. Number AU-B-2006275999

PCT Pub. Number WO2007/016018

Priority 11/195,268 01.08.05 US

Filing date 24 July 2006

Wipo publication date 8 February 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/016018 Priority application(s): WO2007/016018

2 February 2012 Application Accepted

  Published as AU-B-2006275999

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006276004-Methods and systems for utilization of resources of contention under any load to facilitate desired bandwidth across single or multiple classes of devices

2006275993-Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation